aluates Reports

$ 0.0

Automative

Global Exosome-mediated Delivery System Market Research Report 2026

Published Date: 2026-01-23

Report Code: QYRE-Auto-28H18321

Global Exosome mediated Delivery System Market Research Report 2024

BUY CHAPTERS

Global Exosome-mediated Delivery System Market Research Report 2026

Code: QYRE-Auto-28H18321

Report

2026-01-23

Pages:116

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Creative Proteomics

Creative Biogene

Creative-Biolabs

Creative Biostructure

Evox Therapeutics Ltd

Boc Sciences

Capricor Therapeutics

Protheragen-ING

ILIAS Biologics Inc.

Allife Medicine

EVLiXiR

VesiCURE Therapeutics

Lonza(Codiak Biosciences)

Exosome-mediated Delivery System Market

The global Exosome-mediated Delivery System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

With the advantages of safety, high biocompatibility, high bioavailability, and the ability to penetrate the blood-brain barrier, exosomes have become increasingly promising and potential carriers for RNA drug delivery. Exosomes are small extracellular vesicles released by cells, playing a crucial role in communication between different cell types. Exosomes offer a promising alternative for RNA delivery. Exosomes, unlike other vectors for gene delivery, present unique advantages such that exosomes are a cell-free natural system for ferrying RNA between cells, robust exosomal membrane can protect the RNA/gene of interest from digestion, and exosomes are rapidly taken up by target cells making them a more efficient vehicle for gene delivery. They are generally well-tolerated by the immune system, reducing the risk of adverse reactions. Additionally, they exhibit natural targeting capabilities, allowing them to selectively deliver their cargo to specific cell types or tissues. This ability to target specific cells greatly enhances the therapeutic potential of exosomes for RNA delivery.

The North American market for Exosome-mediated Delivery System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Exosome-mediated Delivery System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Exosome-mediated Delivery System in Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Exosome-mediated Delivery System include Creative Proteomics, Creative Biogene, Creative Biolabs, Creative Biostructure, Evox Therapeutics Ltd, BOC Sciences, Capricor Therapeutics, ILIAS Biologics Inc., Protheragen-ING, Allife Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Exosome-mediated Delivery System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Exosome-mediated Delivery System. The Exosome-mediated Delivery System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Exosome-mediated Delivery System market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Exosome-mediated Delivery System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Exosome-mediated Delivery System Market Report

Report Metric	Details
Report Name	Exosome-mediated Delivery System Market
Segment by Type	Proteins Nucleotides Small Molecule
Segment by Application	Gene Therapy Drug Delivery Vaccine Development
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Creative Proteomics, Creative Biogene, Creative Biolabs, Creative Biostructure, Evox Therapeutics Ltd, BOC Sciences, Capricor Therapeutics, ILIAS Biologics Inc., Protheragen-ING, Allife Medicine, EVLiXiR, VesiCURE Therapeutics, Lonza(Codiak Biosciences)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Exosome-mediated Delivery System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Exosome-mediated Delivery System Market report?

Ans: The main players in the Exosome-mediated Delivery System Market are Creative Proteomics, Creative Biogene, Creative Biolabs, Creative Biostructure, Evox Therapeutics Ltd, BOC Sciences, Capricor Therapeutics, ILIAS Biologics Inc., Protheragen-ING, Allife Medicine, EVLiXiR, VesiCURE Therapeutics, Lonza(Codiak Biosciences)

What are the Application segmentation covered in the Exosome-mediated Delivery System Market report?

Ans: The Applications covered in the Exosome-mediated Delivery System Market report are Gene Therapy, Drug Delivery, Vaccine Development

What are the Type segmentation covered in the Exosome-mediated Delivery System Market report?

Ans: The Types covered in the Exosome-mediated Delivery System Market report are Proteins, Nucleotides, Small Molecule

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Exosome-mediated Delivery System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Proteins

1.2.3 Nucleotides

1.2.4 Small Molecule

1.3 Market by Application

1.3.1 Global Exosome-mediated Delivery System Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Gene Therapy

1.3.3 Drug Delivery

1.3.4 Vaccine Development

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Exosome-mediated Delivery System Market Perspective (2021–2032)

2.2 Global Exosome-mediated Delivery System Growth Trends by Region

2.2.1 Global Exosome-mediated Delivery System Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Exosome-mediated Delivery System Historic Market Size by Region (2021–2026)

2.2.3 Exosome-mediated Delivery System Forecasted Market Size by Region (2027–2032)

2.3 Exosome-mediated Delivery System Market Dynamics

2.3.1 Exosome-mediated Delivery System Industry Trends

2.3.2 Exosome-mediated Delivery System Market Drivers

2.3.3 Exosome-mediated Delivery System Market Challenges

2.3.4 Exosome-mediated Delivery System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Exosome-mediated Delivery System Players by Revenue

3.1.1 Global Top Exosome-mediated Delivery System Players by Revenue (2021–2026)

3.1.2 Global Exosome-mediated Delivery System Revenue Market Share by Players (2021–2026)

3.2 Global Top Exosome-mediated Delivery System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Exosome-mediated Delivery System Revenue

3.4 Global Exosome-mediated Delivery System Market Concentration Ratio

3.4.1 Global Exosome-mediated Delivery System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Exosome-mediated Delivery System Revenue in 2025

3.5 Global Key Players of Exosome-mediated Delivery System Head Offices and Areas Served

3.6 Global Key Players of Exosome-mediated Delivery System, Products and Applications

3.7 Global Key Players of Exosome-mediated Delivery System, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Exosome-mediated Delivery System Breakdown Data by Type

4.1 Global Exosome-mediated Delivery System Historic Market Size by Type (2021–2026)

4.2 Global Exosome-mediated Delivery System Forecasted Market Size by Type (2027–2032)

5 Exosome-mediated Delivery System Breakdown Data by Application

5.1 Global Exosome-mediated Delivery System Historic Market Size by Application (2021–2026)

5.2 Global Exosome-mediated Delivery System Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Exosome-mediated Delivery System Market Size (2021–2032)

6.2 North America Exosome-mediated Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Exosome-mediated Delivery System Market Size by Country (2021–2026)

6.4 North America Exosome-mediated Delivery System Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Exosome-mediated Delivery System Market Size (2021–2032)

7.2 Europe Exosome-mediated Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Exosome-mediated Delivery System Market Size by Country (2021–2026)

7.4 Europe Exosome-mediated Delivery System Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Exosome-mediated Delivery System Market Size (2021–2032)

8.2 Asia-Pacific Exosome-mediated Delivery System Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Exosome-mediated Delivery System Market Size by Region (2021–2026)

8.4 Asia-Pacific Exosome-mediated Delivery System Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Exosome-mediated Delivery System Market Size (2021–2032)

9.2 Latin America Exosome-mediated Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Exosome-mediated Delivery System Market Size by Country (2021–2026)

9.4 Latin America Exosome-mediated Delivery System Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Exosome-mediated Delivery System Market Size (2021–2032)

10.2 Middle East & Africa Exosome-mediated Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Exosome-mediated Delivery System Market Size by Country (2021–2026)

10.4 Middle East & Africa Exosome-mediated Delivery System Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Creative Proteomics

11.1.1 Creative Proteomics Company Details

11.1.2 Creative Proteomics Business Overview

11.1.3 Creative Proteomics Exosome-mediated Delivery System Introduction

11.1.4 Creative Proteomics Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.1.5 Creative Proteomics Recent Development

11.2 Creative Biogene

11.2.1 Creative Biogene Company Details

11.2.2 Creative Biogene Business Overview

11.2.3 Creative Biogene Exosome-mediated Delivery System Introduction

11.2.4 Creative Biogene Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.2.5 Creative Biogene Recent Development

11.3 Creative Biolabs

11.3.1 Creative Biolabs Company Details

11.3.2 Creative Biolabs Business Overview

11.3.3 Creative Biolabs Exosome-mediated Delivery System Introduction

11.3.4 Creative Biolabs Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.3.5 Creative Biolabs Recent Development

11.4 Creative Biostructure

11.4.1 Creative Biostructure Company Details

11.4.2 Creative Biostructure Business Overview

11.4.3 Creative Biostructure Exosome-mediated Delivery System Introduction

11.4.4 Creative Biostructure Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.4.5 Creative Biostructure Recent Development

11.5 Evox Therapeutics Ltd

11.5.1 Evox Therapeutics Ltd Company Details

11.5.2 Evox Therapeutics Ltd Business Overview

11.5.3 Evox Therapeutics Ltd Exosome-mediated Delivery System Introduction

11.5.4 Evox Therapeutics Ltd Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.5.5 Evox Therapeutics Ltd Recent Development

11.6 BOC Sciences

11.6.1 BOC Sciences Company Details

11.6.2 BOC Sciences Business Overview

11.6.3 BOC Sciences Exosome-mediated Delivery System Introduction

11.6.4 BOC Sciences Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.6.5 BOC Sciences Recent Development

11.7 Capricor Therapeutics

11.7.1 Capricor Therapeutics Company Details

11.7.2 Capricor Therapeutics Business Overview

11.7.3 Capricor Therapeutics Exosome-mediated Delivery System Introduction

11.7.4 Capricor Therapeutics Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.7.5 Capricor Therapeutics Recent Development

11.8 ILIAS Biologics Inc.

11.8.1 ILIAS Biologics Inc. Company Details

11.8.2 ILIAS Biologics Inc. Business Overview

11.8.3 ILIAS Biologics Inc. Exosome-mediated Delivery System Introduction

11.8.4 ILIAS Biologics Inc. Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.8.5 ILIAS Biologics Inc. Recent Development

11.9 Protheragen-ING

11.9.1 Protheragen-ING Company Details

11.9.2 Protheragen-ING Business Overview

11.9.3 Protheragen-ING Exosome-mediated Delivery System Introduction

11.9.4 Protheragen-ING Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.9.5 Protheragen-ING Recent Development

11.10 Allife Medicine

11.10.1 Allife Medicine Company Details

11.10.2 Allife Medicine Business Overview

11.10.3 Allife Medicine Exosome-mediated Delivery System Introduction

11.10.4 Allife Medicine Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.10.5 Allife Medicine Recent Development

11.11 EVLiXiR

11.11.1 EVLiXiR Company Details

11.11.2 EVLiXiR Business Overview

11.11.3 EVLiXiR Exosome-mediated Delivery System Introduction

11.11.4 EVLiXiR Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.11.5 EVLiXiR Recent Development

11.12 VesiCURE Therapeutics

11.12.1 VesiCURE Therapeutics Company Details

11.12.2 VesiCURE Therapeutics Business Overview

11.12.3 VesiCURE Therapeutics Exosome-mediated Delivery System Introduction

11.12.4 VesiCURE Therapeutics Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.12.5 VesiCURE Therapeutics Recent Development

11.13 Lonza(Codiak Biosciences)

11.13.1 Lonza(Codiak Biosciences) Company Details

11.13.2 Lonza(Codiak Biosciences) Business Overview

11.13.3 Lonza(Codiak Biosciences) Exosome-mediated Delivery System Introduction

11.13.4 Lonza(Codiak Biosciences) Revenue in Exosome-mediated Delivery System Business (2021–2026)

11.13.5 Lonza(Codiak Biosciences) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Creative Proteomics

Creative Biogene

Creative-Biolabs

Creative Biostructure

Evox Therapeutics Ltd

Boc Sciences

Capricor Therapeutics

Protheragen-ING

ILIAS Biologics Inc.

Allife Medicine

EVLiXiR

VesiCURE Therapeutics

Lonza(Codiak Biosciences)

List of Tables

Table 1. Global Exosome-mediated Delivery System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Proteins

Table 3. Key Players of Nucleotides

Table 4. Key Players of Small Molecule

Table 5. Global Exosome-mediated Delivery System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Exosome-mediated Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Exosome-mediated Delivery System Market Size by Region (US$ Million), 2021–2026

Table 8. Global Exosome-mediated Delivery System Market Share by Region (2021–2026)

Table 9. Global Exosome-mediated Delivery System Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Exosome-mediated Delivery System Market Share by Region (2027–2032)

Table 11. Exosome-mediated Delivery System Market Trends

Table 12. Exosome-mediated Delivery System Market Drivers

Table 13. Exosome-mediated Delivery System Market Challenges

Table 14. Exosome-mediated Delivery System Market Restraints

Table 15. Global Exosome-mediated Delivery System Revenue by Players (US$ Million), 2021–2026

Table 16. Global Exosome-mediated Delivery System Market Share by Players (2021–2026)

Table 17. Global Top Exosome-mediated Delivery System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Exosome-mediated Delivery System Revenue, 2025

Table 18. Ranking of Global Top Exosome-mediated Delivery System Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Exosome-mediated Delivery System Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Exosome-mediated Delivery System, Headquarters and Area Served

Table 21. Global Key Players of Exosome-mediated Delivery System, Products and Applications

Table 22. Global Key Players of Exosome-mediated Delivery System, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Exosome-mediated Delivery System Market Size by Type (US$ Million), 2021–2026

Table 25. Global Exosome-mediated Delivery System Revenue Market Share by Type (2021–2026)

Table 26. Global Exosome-mediated Delivery System Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Exosome-mediated Delivery System Revenue Market Share by Type (2027–2032)

Table 28. Global Exosome-mediated Delivery System Market Size by Application (US$ Million), 2021–2026

Table 29. Global Exosome-mediated Delivery System Revenue Market Share by Application (2021–2026)

Table 30. Global Exosome-mediated Delivery System Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Exosome-mediated Delivery System Revenue Market Share by Application (2027–2032)

Table 32. North America Exosome-mediated Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Exosome-mediated Delivery System Market Size by Country (US$ Million), 2021–2026

Table 34. North America Exosome-mediated Delivery System Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Exosome-mediated Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Exosome-mediated Delivery System Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Exosome-mediated Delivery System Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Exosome-mediated Delivery System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Exosome-mediated Delivery System Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Exosome-mediated Delivery System Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Exosome-mediated Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Exosome-mediated Delivery System Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Exosome-mediated Delivery System Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Exosome-mediated Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Exosome-mediated Delivery System Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Exosome-mediated Delivery System Market Size by Country (US$ Million), 2027–2032

Table 47. Creative Proteomics Company Details

Table 48. Creative Proteomics Business Overview

Table 49. Creative Proteomics Exosome-mediated Delivery System Product

Table 50. Creative Proteomics Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 51. Creative Proteomics Recent Development

Table 52. Creative Biogene Company Details

Table 53. Creative Biogene Business Overview

Table 54. Creative Biogene Exosome-mediated Delivery System Product

Table 55. Creative Biogene Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 56. Creative Biogene Recent Development

Table 57. Creative Biolabs Company Details

Table 58. Creative Biolabs Business Overview

Table 59. Creative Biolabs Exosome-mediated Delivery System Product

Table 60. Creative Biolabs Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 61. Creative Biolabs Recent Development

Table 62. Creative Biostructure Company Details

Table 63. Creative Biostructure Business Overview

Table 64. Creative Biostructure Exosome-mediated Delivery System Product

Table 65. Creative Biostructure Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 66. Creative Biostructure Recent Development

Table 67. Evox Therapeutics Ltd Company Details

Table 68. Evox Therapeutics Ltd Business Overview

Table 69. Evox Therapeutics Ltd Exosome-mediated Delivery System Product

Table 70. Evox Therapeutics Ltd Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 71. Evox Therapeutics Ltd Recent Development

Table 72. BOC Sciences Company Details

Table 73. BOC Sciences Business Overview

Table 74. BOC Sciences Exosome-mediated Delivery System Product

Table 75. BOC Sciences Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 76. BOC Sciences Recent Development

Table 77. Capricor Therapeutics Company Details

Table 78. Capricor Therapeutics Business Overview

Table 79. Capricor Therapeutics Exosome-mediated Delivery System Product

Table 80. Capricor Therapeutics Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 81. Capricor Therapeutics Recent Development

Table 82. ILIAS Biologics Inc. Company Details

Table 83. ILIAS Biologics Inc. Business Overview

Table 84. ILIAS Biologics Inc. Exosome-mediated Delivery System Product

Table 85. ILIAS Biologics Inc. Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 86. ILIAS Biologics Inc. Recent Development

Table 87. Protheragen-ING Company Details

Table 88. Protheragen-ING Business Overview

Table 89. Protheragen-ING Exosome-mediated Delivery System Product

Table 90. Protheragen-ING Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 91. Protheragen-ING Recent Development

Table 92. Allife Medicine Company Details

Table 93. Allife Medicine Business Overview

Table 94. Allife Medicine Exosome-mediated Delivery System Product

Table 95. Allife Medicine Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 96. Allife Medicine Recent Development

Table 97. EVLiXiR Company Details

Table 98. EVLiXiR Business Overview

Table 99. EVLiXiR Exosome-mediated Delivery System Product

Table 100. EVLiXiR Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 101. EVLiXiR Recent Development

Table 102. VesiCURE Therapeutics Company Details

Table 103. VesiCURE Therapeutics Business Overview

Table 104. VesiCURE Therapeutics Exosome-mediated Delivery System Product

Table 105. VesiCURE Therapeutics Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 106. VesiCURE Therapeutics Recent Development

Table 107. Lonza(Codiak Biosciences) Company Details

Table 108. Lonza(Codiak Biosciences) Business Overview

Table 109. Lonza(Codiak Biosciences) Exosome-mediated Delivery System Product

Table 110. Lonza(Codiak Biosciences) Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026

Table 111. Lonza(Codiak Biosciences) Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Exosome-mediated Delivery System Picture

Figure 2. Global Exosome-mediated Delivery System Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Exosome-mediated Delivery System Market Share by Type: 2025 vs 2032

Figure 4. Proteins Features

Figure 5. Nucleotides Features

Figure 6. Small Molecule Features

Figure 7. Global Exosome-mediated Delivery System Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Exosome-mediated Delivery System Market Share by Application: 2025 vs 2032

Figure 9. Gene Therapy Case Studies

Figure 10. Drug Delivery Case Studies

Figure 11. Vaccine Development Case Studies

Figure 12. Exosome-mediated Delivery System Report Years Considered

Figure 13. Global Exosome-mediated Delivery System Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Exosome-mediated Delivery System Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Exosome-mediated Delivery System Market Share by Region: 2025 vs 2032

Figure 16. Global Exosome-mediated Delivery System Market Share by Players in 2025

Figure 17. Global Exosome-mediated Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Exosome-mediated Delivery System Revenue in 2025

Figure 19. North America Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Exosome-mediated Delivery System Market Share by Country (2021–2032)

Figure 21. United States Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Exosome-mediated Delivery System Market Share by Country (2021–2032)

Figure 25. Germany Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Exosome-mediated Delivery System Market Share by Region (2021–2032)

Figure 33. China Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Exosome-mediated Delivery System Market Share by Country (2021–2032)

Figure 41. Mexico Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Exosome-mediated Delivery System Market Share by Country (2021–2032)

Figure 45. Israel Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Creative Proteomics Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 49. Creative Biogene Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 50. Creative Biolabs Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 51. Creative Biostructure Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 52. Evox Therapeutics Ltd Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 53. BOC Sciences Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 54. Capricor Therapeutics Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 55. ILIAS Biologics Inc. Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 56. Protheragen-ING Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 57. Allife Medicine Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 58. EVLiXiR Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 59. VesiCURE Therapeutics Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 60. Lonza(Codiak Biosciences) Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Exosome Technologies Market Research Report 2025

Global Exosome Service Market Research Report 2025

Global Exosome Therapy Technology Market Research Report 2025

Global Exosome Harvesting System Market Research Report 2024

Global Exosome Kit Market Research Report 2024

Global Exosome Analyzers Market Research Report 2025

Exosome Analysis Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

End to End Exosome Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Exosome Research Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Exosome Detection Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Exosome Extraction Service Market Research Report 2024

Global Exosome CRO Market Research Report 2024

Global Exosome Isolation and Extraction Services Market Research Report 2024

Exosome Engineering Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Exosome Extraction Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Exosome Particle Size Analyzers Market Research Report 2025

Global Exosome CDMO Market Research Report 2024

Global Exosome Diagnostic and Therapeutics Market Research Report 2024

Exosome Sample Oustomization Processing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions